Jump To Central Area
:::
:::
William Hung

William Hung / 洪偉仁
Personal Webpage
Areas of Expertise
- Biotech and Healthcare Investment, Medical Devices, Smart Healthcare, Mergers and Acquisitions, Portfolio Management, Cross-Border Strategic Partnerships, Industry-Academia Collaboration and Technology Transfer, Startup Mentoring
Current Positions
- External Consultant, Biomedical Translation Research Center, Academia Sinica (2020/03–Present)
Professional Experience (Selected)
- Chief Investment Officer / Foxconn Technology Co., Ltd. (2022–2024)
- Chief Strategy Officer, CHC Healthcare Co., Ltd. (2020–2022)
- Distinguished Visiting Lecturer / COO, Global Research-Industry Alliance, National Cheng Kung University (2017–2019)
- Special Assistant to the Chairman, CHC Healthcare Holdings Co., Ltd. (2015–2017)
- Vice President, H&Q AP Biomed Co., Ltd. (2007–2014)
- Chief Investment Officer / Foxconn Technology Co., Ltd. (2022–2024)
- Chief Strategy Officer, CHC Healthcare Co., Ltd. (2020–2022)
- Distinguished Visiting Lecturer / COO, Global Research-Industry Alliance, National Cheng Kung University (2017–2019)
- Special Assistant to the Chairman, CHC Healthcare Holdings Co., Ltd. (2015–2017)
- Vice President, H&Q AP Biomed Co., Ltd. (2007–2014)
Additional Experience
- Board Director, Immune Works Co., Ltd.
- Independent Director, Gallant Precision Machining Co.
- CEO, Tanvex Biologics Taiwan
- Supervisor, Swissray
- Supervisor, Apexcella Bio.
- AVP, Industrial Bank Taiwan(IBT) Mgmt. Co., Ltd. (Biotech VC)
- Investment Manager, UniPac Mgmt. Co., Ltd. (Biotech VC)
- Special Assistant to the CEO, Development Center for Biotechnology
- Senior Specialist, Superintendent’s Office, Tzu Ai General Hospital
- Director, Medical Research Department, Hua Chi Hospital
Education
- M.S., Graduate Institute of Immunology, College of Medicine, National Taiwan University (1994-1996)